Nick Pizzie

Insider Reports History

Location
New York, NY
Signature
/s/ Nick Pizzie
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nick Pizzie:

Company Role Class Num Shares Value Price $ Report Date Ownership
Axsome Therapeutics, Inc. Chief Financial Officer Common Stock 42,588 $8,003,136 $187.92 22 Jan 2026 Direct
Axsome Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 18,570 $1,235,073 $131.07 26 Feb 2026 Direct
Axsome Therapeutics, Inc. Chief Financial Officer Common Stock 488 $89,128 $182.64 22 Jan 2026 Indirect
Axsome Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 105,000 $0 $3.50 22 Jan 2026 Direct

Insider Reports Filed by Nick Pizzie

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AXSM Axsome Therapeutics, Inc. 26 Feb 2026 1 $0 4 Chief Financial Officer 27 Feb 2026, 19:10
AXSM Axsome Therapeutics, Inc. 22 Jan 2026 3 -$2,213,040 4 Chief Financial Officer 23 Jan 2026, 19:00
AXSM Axsome Therapeutics, Inc. 21 Feb 2025 3 $0 4 Chief Financial Officer 25 Feb 2025, 19:54
AXSM Axsome Therapeutics, Inc. 13 Feb 2025 6 -$1,951,530 4 Chief Financial Officer 14 Feb 2025, 21:20
AXSM Axsome Therapeutics, Inc. 27 Feb 2024 2 $0 4 CHIEF FINANCIAL OFFICER 29 Feb 2024, 18:25
AXSM Axsome Therapeutics, Inc. 02 Mar 2023 2 $0 4 CHIEF FINANCIAL OFFICER 06 Mar 2023, 17:14
AXSM Axsome Therapeutics, Inc. 04 Mar 2022 2 $0 4 CHIEF FINANCIAL OFFICER 08 Mar 2022, 16:02
AXSM Axsome Therapeutics, Inc. 18 Nov 2021 4 +$33,676 4 CHIEF FINANCIAL OFFICER 22 Nov 2021, 06:31
AXSM Axsome Therapeutics, Inc. 12 Nov 2021 1 $0 4 CHIEF FINANCIAL OFFICER 15 Nov 2021, 18:55